C-Reactive Protein Serum Level is a Valuable and Simple Prognostic Marker in Non Hodgkin's Lymphoma

References

• Akira S., Taga T., Kishimoto T. Interleukin-6 in biology and medicine. Adv Immunol 1993; 54: 1–78
   PubMed Web of Science ®Google Scholar
• Klein B., Zhang X. G., Lu Z. Y., Bataille R. Interleukin-6 in human multiple myeloma. Blood 1995; 85: 863–872
   PubMed Web of Science ®Google Scholar
• Hsu S. M., Waldron J. A., Jr., Fink L., King C., Xie S. S., Mansouri A., Barlogie B. Pathogenic significance of interleukin-6 in angioimmunoblastic lymphadenopathy-type T-cell lymphoma. Hum Pathol 1993; 24: 126–131
   PubMed Web of Science ®Google Scholar
• Freeman G. J., Freedman A. S., Rabinowe S. N., Segil J. M., Horowitz J., Rosen K., Whitman J. F., Nadler L. M. Interleukin 6 gene expression in normal and neoplastic B cells. J Clin Invest 1989; 83: 1512–1518
   PubMed Web of Science ®Google Scholar
• Bock G. H., Long C. A., Riley M. L., White J. D., Kurman C. C., Fleisher T. A., Tsokos M., Brown M., Serbousek D., Schwietermann W. D. Characterization of a new IL-6-dependent human B-lymphoma cell line in long term culture. Cytokine 1993; 5: 480–489
   PubMed Web of Science ®Google Scholar
• Yee C., Biondi A., Wang X. H., Iscove N. N., De Sousa J., Aarden L. A., Wong G. G., Clark S. C., Messner H. A., Min-Den M. D. A possible autocrine role for interleukin-6 in two lymphoma cell lines. Blood 1989; 74: 798–804
   PubMed Web of Science ®Google Scholar
• Hsu S. M., Waldron J. W., Jr., Hsu P. L., Hough A. J., Jr. Cytokines in malignant lymphomas: review and prospective evaluation. Hum Pathol 1993; 24: 1040–1057
   PubMed Web of Science ®Google Scholar
• Voorzanger N., Touitou R., Garcia E., Delecluse H. J., Rousset F., Joab I., Favrot M. C., Blay J. Y. Interleukin (IL)-10 and IL-6 are produced in vivo by non-Hodgkin's lymphoma cells and act as cooperative growth factors. Cancer Res 1996; 56: 5499–5505
   PubMed Web of Science ®Google Scholar
• Emilie D., Coumbaras J., Raphael M., Devergne O., Delecluse H. J., Gisselbrecht C., Michiels J. F., Van Damme J., Taga T., Kishimoto T. Interleukin-6 production in high-grade B lymphomas: correlation with the presence of malignant immunoblasts in acquired immunodeficiency syndrome and in human immunodeficiency virus-seronegative patients. Blood 1992; 80: 498–504
   PubMed Web of Science ®Google Scholar
• Emilie D., Leger-Ravet M. B., Devergne O., Raphael M., Peuchmaur M., Coumbaras J., Crevon M. C., Galanaud P. Intratumoral production of IL-6 in B cell chronic lymphocytic leukemia and B lymphomas. Leuk Lymphoma 1993; 11: 411–417
   PubMed Web of Science ®Google Scholar
• Takeshita M., Sumiyoshi Y., Masuda Y., Ohshima K., Yoshida T., Kikuchi M., Muller H. Cytokine (interleukin-1 alpha, interleukin-1 beta, tumor necrosis factor alpha, and interleukin-6)-possessing cells in lymph nodes of malignant lymphoma. Pathol Res Pract 1993; 189: 18–25
   PubMed Web of Science ®Google Scholar
• Woodroofe C., Muller W., Ruther U. Long-term consequences of interleukin-6 overexpression in transgenic mice. DNA Cell Biol 1992; 11: 587–592
   PubMed Web of Science ®Google Scholar
• Yee C., Sutcliffe S., Messner H. A., Minden M. D. Interleukin-6 levels in the plasma of patients with lymphoma. Leak Lymphoma 1992; 7: 123–129
   PubMed Web of Science ®Google Scholar
• Kurzrock R., Redman J., Cabanillas R., Jones D., Rothberg J., Talpaz M. Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms. Cancer Res 1993; 53: 2118–2122
   PubMed Web of Science ®Google Scholar
• Seymour J. F., Talpaz M., Cabanillas R., Wetzler M., Kurzrock R. Serum interleukin-6 levels correlate with prognosis in diffuse large- cell lymphoma. J Clin Oncol 1995; 13: 575–582
   PubMed Web of Science ®Google Scholar
• Majello B., Arcone R., Toniatti C., Ciliberto G. Constitutive and IL-6-induced nuclear factors that interact with the human C-reactive protein promoter. EMBO J 1990; 9: 457–465
   PubMed Web of Science ®Google Scholar
• Steel D. M., Whitehead A. S. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today 1994; 15: 81–88
   PubMedGoogle Scholar
• Klein B., Wijdenes J., Zhang X. G., Jourdan M., Boiron J. M., Brochier J., Liautard J., Merlin M., Clement C., Morel-Pournier B. Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia. Blood 1991; 78: 1198–1204
   PubMed Web of Science ®Google Scholar
• Lu Z. Y., Brailly H., Wijdenes J., Bataille R., Rossi J. R, Klein B. Measurement of whole body interleukin-6 (IL-6) production: prediction of the efficacy of anti-lL-6 treatments. Blood 1995; 86: 3123–3131
   PubMed Web of Science ®Google Scholar
• Bataille R., Boccadoro M., Klein B., Durie B., Pileri A. C-reactive protein and beta-2 microglobulin produce a simple and powerful myeloma staging system. Blood 1992; 80: 733–737
   PubMed Web of Science ®Google Scholar
• A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 1993; 329: 987–994
   PubMed Web of Science ®Google Scholar
• National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project. Cancer 1982; 49: 2112–2135
   PubMed Web of Science ®Google Scholar
• Rodriguez C., Commes T., Robert J., Rossi J. R. Expression of P-glycoprotein and anionic glutathione S-transferase genes in non-Hodgkin's lymphoma. Leuk Res 1993; 17: 149–156
   PubMed Web of Science ®Google Scholar
• Baumann H., Gauldie J. The acute phase response. Immunol Today 1994; 15: 74–80
   PubMedGoogle Scholar
• Diebold S., Peuchmaur M., Emilie D., Crevon M. C., Solal-Celigny P., Tertian G., Galanaud P. IL-6 mRNA expression in CD25 positive malignant lymphomas. Eur Cytokine Netw 1992; 3: 313–319
   PubMedGoogle Scholar
• Kato H., Kinoshita T., Suzuki S., Nagasaka T., Murate T., Saito H., Hotta T. Elevated serum interleukin-6 (IL-6) is derived from neoplastic lymphoid cells in patients with B-cell non-Hodgkin's lymphoma: correlation with extent of IL-6 expression and serum concentration. Br J Haematol 1996; 92: 1014–1021
   PubMed Web of Science ®Google Scholar
• Pettersson T., Metsarinne K., Teppo A. M., Fyhrquist P. Immunoreactive interleukin-6 in serum of patients with B-lymphoproliferative diseases. J Intern Med 1992; 232: 439–442
   PubMed Web of Science ®Google Scholar
• Emilie D., Wijdenes J., Gisselbrecht C., Jarrousse B., Billaud E., Blay J. Y., Gabarre J., Gaillard J. R, Brochier J., Raphael M. Administration of an anti-interleukin-6 monoclonal antibody to patients with acquired immunodeficiency syndrome and lymphoma: effect on lymphoma growth and on B clinical symptoms. Blood 1994; 84: 2472–2479
   PubMed Web of Science ®Google Scholar
• Poa R., Massaia M., Cardona S., Tos A. G., Bianchi A., Attisano C., Guarini A., Di Celle P R, Pierro M. T. Production of tumor necrosis factor-alpha by B-cell chronic lymphocytic leukemia cells: a possible regulatory role of TNP in the progression of the disease. Blood 1990; 76: 393–400
   PubMed Web of Science ®Google Scholar
• Kretschmer C., Jones D. B., Morrison K., Schluter C., Feist W., Ulmer A. J., Arnoldi J., Matthes J., Diamantstein T., Plad H. D. Tumor necrosis factor alpha and lymphotoxin production in Hodgkin's disease. Am J Pathol 1990; 137: 341–351
   PubMed Web of Science ®Google Scholar
• Barak V., Nisman B., Dann E. J., Kalickman J., Ruchlemer R., Bennett M. A., Polliack A. Serum Interleukin 1 beta Levels as a marker in hairy cell Leukemia; correlation with disease status and sIL-2R Levels. Leuk Lymphoma 1994; 14(Suppl, 1)33–39
   PubMed Web of Science ®Google Scholar
• Blay J. Y., Negrier S., Combaret V., Attali S., Goillot E., Merrouche Y., Mercatello A., Ravault A., Tourani J. M., Moskovtchenko J. R. Serum level of interleukin 6 as a prognosis factor in metastatic renal cell carcinoma. Cancer Res 1992; 52: 3317–3322
   PubMed Web of Science ®Google Scholar